TP53 and breast carcinoma: This is the first study to evaluate the relationship between APOBEC3B mRNA expression and the clinicopathological factors, prognosis, and TP53 mutation status in a large cohort of Japanese breast cancer patients including tumors lacking APOBEC3B mRNA expression.